Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Bonnell Brian Michael	2. Date of Event Requiring Statement (MM/DD/YYYY) 3/3/2020	3. Issuer Name and Ticker or Trading Symbol ICU MEDICAL INC/DE [ICUI]
(Last)        (First)        (Middle) 951 CALLE AMANECER	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Chief Financial Officer /
(Street) SAN CLEMENTE, CA 92673       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (1)	(2)	8/16/2021 (3)	Common Stock	2416	$0.0 (4)	D
Common Stock (1)	(2)	3/6/2022 (3)	Common Stock	2166	$0.0 (4)	D

Explanation of Responses:
(1)	These securities are Restricted Stock Units.
(2)	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
(3)	These are restricted stock units that fully vest 3 years from the grant date.
(4)	There is neither a purchase price nor an exercise price for the Restricted Stock Units.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bonnell Brian Michael 951 CALLE AMANECER SAN CLEMENTE, CA 92673			Chief Financial Officer

Signatures
By: Paula Darbyshire, Attorney-in-fact For: Brian Bonnell		3/9/2020
**Signature of Reporting Person		Date